Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Surgery
Share your love
EO2002: Non-Surgical Solution for Corneal Edema
Emmecell has announced positive results from its U.S. multicenter Phase 1 trial evaluating EO2002, an innovative non-surgical cell therapy for corneal edema. The randomized, double-masked trial demonstrated significant improvements in best corrected visual acuity (BCVA) and reductions in central corneal…
Positive Phase 3 Results for MELT-300 Sedation
Melt Pharmaceuticals has reported promising topline results from the pivotal Phase 3 trial of MELT-300, a novel, non-intravenous, non-opioid sedation tablet developed for use during cataract surgeries. The study, conducted under an FDA-approved Special Protocol Assessment (SPA) agreement, demonstrated that…
Ray Tracing Optimization – Myopic LASIK & AI
Laser-assisted in situ keratomileusis (LASIK) has become one of the most effective and safe methods for correcting refractive error with laser corneal intervention, as evidenced by the long and large number of publications in the peer-reviewed literature. In recent years,…
SERI and ZEISS Partner to Improve Vision Care
The Singapore Eye Research Institute (SERI) and Carl Zeiss Meditec have launched a groundbreaking collaboration aimed at advancing cataract and refractive surgery outcomes. The initiative, called Ophthalmic Tech Innovation by ZEISS and SERI (OPTIZS), involves a combined investment of nearly…
Alcon’s IOL Faces Probe by CDSCO
The Central Drugs Standard Control Organisation (CDSCO) has formed a committee to investigate allegations of quality issues with an intraocular lens (IOL) supplied by Alcon. The Swiss-American company specializes in eye care products, including lenses for cataract surgery. Specifics of…
OBN Spotlight TV: Interview with Hillary A. Golden
In late October, Medicare introduced proposed Local Coverage Determinations (LCDs) that aimed to impose restrictions on Minimally Invasive Glaucoma Surgery (MIGS) procedures. These LCDs were met with significant concern and opposition from medical professionals, patient advocacy groups, and the ophthalmology…
Top 15 International Ophthalmology Congresses in 2024
As the field of ophthalmology continues to advance, a plethora of international congresses offer opportunities for professionals to explore the latest innovations, share insights, and foster collaborations. Here is a comprehensive list of the top 15 international ophthalmology conferences scheduled…
What Is Ophthalmia Neonatorum? | OBN
Ophthalmia neonatorum, also known as neonatal conjunctivitis, is an inflammation of the conjunctiva (the clear membrane covering the white part of the eye) that occurs in newborns. It is a serious condition that can lead to blindness if left untreated.…
The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: Report 17, a risk factor model for posterior capsule rupture | Eye – Nature
The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: Report 17, a risk factor model for posterior capsule rupture | Eye Nature Source: Author: | Date: 2024-09-19 07:00:00 Source: Author: | Date: 2024-09-19 07:00:00
Osheru Receives Funding for Ziplyft Device for Blepharoplasty
Osheru announced the successful completion of a $4.7 million funding round aimed at accelerating the development and commercialization of its Ziplyft device for blepharoplasty surgery. The funding round was oversubscribed and led by a consortium of investors including individuals, family…